造血干细胞移植后间质性肺炎18例分析_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

文钦 ,  贾永前 , 何川 , 陈心传 , 李建军 , 刘霆

Corresponding author：

贾永前, Email: jia_yq@163.com

Keywords：

造血干细胞; 移植; 间质性肺炎

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

间质性肺炎（IP）是造血干细胞移植后严重的并发症之一，临床表现缺乏特异性，病情重，死亡率高，直接影响造血干细胞移植患者的移植后存活率。现对四川大学华西医院1999~2005年期间110例造血干细胞移植患者中发生IP的18例患者临床资料进行回顾性分析，探讨其发病相关危险因素及防治措施

Citation： 文钦,贾永前,何川,陈心传,李建军,刘霆. 造血干细胞移植后间质性肺炎18例分析. Chinese Journal of Respiratory and Critical Care Medicine, 2008, 08(4): 301-303. doi: Copy

1.	邓家栋,杨崇礼,杨天楹,主编.邓家栋临床血液学.上海:上海科学技术出版社,2001: 1655- 1656.
2.	Zaia JA. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone Marrow Transplant, 2002, 29: 633-638.
3.	Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol, 1997, 97: 855-864.
4.	Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med, 2002, 78: 257-262.
5.	Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant, 2001, 28: 425-434.
6.	Bourke SJ. Interstitial lung disease: Progress and Problems. Postgrad Med J, 2006, 82: 494- 499.
7.	Krause H, Hebart H, Jahn G,et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant, 1997,19: 1111-1116.
8.	黄晓军,陆道培.骨髓移植后CMV间质性肺炎.国外医学输血及血液学分册,1996,19:282-284.
9.	Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation.J Infect Dis,1986,153: 478-488.
10.	Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant, 1994, 14 (Suppl 4): S19-S28.
11.	King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med, 2005, 172: 268-279.
12.	Ljungman P, De Bock R, Cordonnier C, et al. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant, 1993, 12: 399-403.
13.	丁昊炜, 任汉云, 郭乃榄, 等. 造血干细胞移植患者巨细胞病毒感染危险因素和疗效分析. 北京大学学报(医学版), 2003, 35: 596-599.

1. 邓家栋,杨崇礼,杨天楹,主编.邓家栋临床血液学.上海:上海科学技术出版社,2001: 1655- 1656.
2. Zaia JA. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone Marrow Transplant, 2002, 29: 633-638.
3. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol, 1997, 97: 855-864.
4. Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med, 2002, 78: 257-262.
5. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant, 2001, 28: 425-434.
6. Bourke SJ. Interstitial lung disease: Progress and Problems. Postgrad Med J, 2006, 82: 494- 499.
7. Krause H, Hebart H, Jahn G,et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant, 1997,19: 1111-1116.
8. 黄晓军,陆道培.骨髓移植后CMV间质性肺炎.国外医学输血及血液学分册,1996,19:282-284.
9. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation.J Infect Dis,1986,153: 478-488.
10. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant, 1994, 14 (Suppl 4): S19-S28.
11. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med, 2005, 172: 268-279.
12. Ljungman P, De Bock R, Cordonnier C, et al. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant, 1993, 12: 399-403.
13. 丁昊炜, 任汉云, 郭乃榄, 等. 造血干细胞移植患者巨细胞病毒感染危险因素和疗效分析. 北京大学学报(医学版), 2003, 35: 596-599.

Previous Article
验证治疗措施的公平——高质量研究促进高质量卫生保健（Ⅵ）

Chinese Journal of Respiratory and Critical Care Medicine

造血干细胞移植后间质性肺炎18例分析

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content